Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation

Analysis of trends over time


  • Ian E. Haines MBBS, FRACP, FAChPM

    1. Department of Medicine, Monash University, Malvern, Victoria, Australia
    2. Medical Oncology and Palliative Care, Melbourne Oncology Group, Cabrini Health, Melbourne, Victoria, Australia
    Search for more papers by this author

No abstract is available for this article.